StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report issued on Thursday. The brokerage set a “sell” rating on the stock. MBRX stock opened at $1.39 on Thursday. Moleculin Biotech has a twelve month low of $1.02 and a twelve month high of $3.99. The business has a […]
Kane Biotech (CVE:KNE – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, May 26th. Kane Biotech (CVE:KNE – Get Rating) last announced its quarterly earnings data on Thursday, March 24th. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$0.41 million […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Krystal Biotech (NASDAQ:KRYS – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. The brokerage currently has a $71.00 price objective on the stock. Zacks Investment Research‘s price target indicates a potential upside of 6.67% […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) and Cardiff Oncology (NASDAQ:CRDF – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Volatility & Risk Krystal Biotech has a beta of […]